Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ibandronic acid 150mg tablets
0606020W0AAADAD
|
Ibandronic acid | Ibandronic acid | Endocrine System | 34,370 |
|
Ibandronic acid 50mg tablets
0606020W0AAABAB
|
Ibandronic acid | Ibandronic acid | Endocrine System | 17,977 |
|
Bonviva 150mg tablets
0606020W0BCAAAD
|
Bonviva | Ibandronic acid | Endocrine System | 659 |
|
Bondronat 50mg tablets
0606020W0BBABAB
|
Bondronat | Ibandronic acid | Endocrine System | 60 |
|
Iasibon 50mg tablets
0606020W0BDAAAB
|
Iasibon | Ibandronic acid | Endocrine System | 12 |
|
Ibandronic acid 3mg/3ml inj pre-filled syringes
0606020W0AAAEAE
|
Ibandronic acid | Ibandronic acid | Endocrine System | 11 |
|
Quodixor 150mg tablets
0606020W0BEAAAD
|
Quodixor | Ibandronic acid | Endocrine System | 10 |
|
Bondronat 2mg/2ml concentrate for inf vials
0606020W0BBADAF
|
Bondronat | Ibandronic acid | Endocrine System | No data available |
|
Bondronat 2mg/2ml solution for infusion ampoules
0606020W0BBAAAA
|
Bondronat | Ibandronic acid | Endocrine System | No data available |
|
Bondronat 6mg/6ml concentrate for inf vials
0606020W0BBACAC
|
Bondronat | Ibandronic acid | Endocrine System | No data available |
|
Bonviva 3mg/3ml solution for injection pre-filled syringes
0606020W0BCABAE
|
Bonviva | Ibandronic acid | Endocrine System | No data available |
|
Ibandronic acid 2mg/2ml solution for infusion ampoules
0606020W0AAAAAA
|
Ibandronic acid | Ibandronic acid | Endocrine System | No data available |
|
Ibandronic acid 2mg/2ml solution for infusion vials
0606020W0AAAFAF
|
Ibandronic acid | Ibandronic acid | Endocrine System | No data available |
|
Ibandronic acid 6mg/6ml solution for infusion vials
0606020W0AAACAC
|
Ibandronic acid | Ibandronic acid | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.